CN109870433B - Buoyancy microsphere probe for quantitative screening of ganglioside and preparation method thereof - Google Patents
Buoyancy microsphere probe for quantitative screening of ganglioside and preparation method thereof Download PDFInfo
- Publication number
- CN109870433B CN109870433B CN201711272434.7A CN201711272434A CN109870433B CN 109870433 B CN109870433 B CN 109870433B CN 201711272434 A CN201711272434 A CN 201711272434A CN 109870433 B CN109870433 B CN 109870433B
- Authority
- CN
- China
- Prior art keywords
- probe
- ganglioside
- buoyancy
- microsphere
- cell surface
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Abstract
The invention relates to a pair of buoyancy microsphere probes for quantitatively screening cell surface ganglioside and a preparation method thereof. The buoyant microsphere probe comprises an extraction probe and a collection probe. The extraction probe takes a silica buoyancy microsphere modified by maleimide as a substrate, and is covalently bonded with a DNA molecule with an endonuclease cutting site and a boric acid terminal. Through covalent recognition of boric acid and sialic acid on the cell surface, the extraction probe can extract biomolecules containing sialic acid on the cell surface through buoyancy. The extracted biomolecules can be released into the solution under the action of endonuclease, and the ganglioside with the nucleic acid fragments combined therein is collected by a collection probe silanized by octadecane through hydrophobic effect, and further fluorescence quantification is carried out on the ganglioside by using in vitro hybridization chain reaction.
Description
One, the technical field
The invention relates to a pair of buoyancy microsphere probes for quantitatively screening cell surface ganglioside and a preparation method thereof.
Second, background Art
Gangliosides are glycosphingolipids comprising one or more sialic acid terminal oligosaccharide chains. They are embedded in the cell membrane via the alkane chains of the ceramide portion, regulate cellular structure, cell adhesion and signal transduction, and serve as receptor sites for microbial toxins, bacteria and viruses. Gangliosides on the cell surface are continuously synthesized and degraded by corresponding highly specific enzymes in a way that increases or decreases the sugar units. Its aberrant glycosylation biological pathways are associated with diseases such as genetic diseases and malignant transformation of cancer. Abnormal overexpression of gangliosides of different subclasses is also strongly associated with the type and progression of tumors. Therefore, screening for gangliosides on the cell surface is of great importance to reveal their associated biological processes and potential tumor progression.
In order to realize quantitative detection of cell surface ganglioside, the patent prepares a pair of functionalized buoyancy microsphere probes, and realizes nondestructive quantitative screening of cell surface ganglioside.
Third, the invention
The purpose of the invention is: based on boric acid mediated covalent recognition of cell surface sialic acid and octadecyl molecule mediated hydrophobic interaction, extraction probes containing nucleic acid cleaving enzyme sites and boric acid terminals and collection probes containing octadecyl molecules were designed, respectively. The sialic acid containing biomolecules on the cell surface are non-destructively extracted using an extraction probe and the extract is released into solution by a nucleic acid cleaving enzyme. Then collecting lipid substance in the release, namely ganglioside, by using a collecting probe, and carrying out hybridization chain reaction through the nucleic acid fragment combined on the ganglioside to obtain a fluorescent signal for quantification. The MCF-7 breast cancer cell line is taken as a model, and the prepared probe realizes the quantification of the cell surface ganglioside.
The buoyant microsphere probe capable of quantitatively screening cell surface ganglioside provided by the invention is shown in figure 1. Using hydroxylated silica buoyancy microspheres as carriers, gradually carrying out amino silanization on the surfaces of the silica buoyancy microspheres, assembling a succinimide and maleimide double-modified polyethylene glycol connector, and further modifying functional DNA molecules with aminophenylboronic acid terminals and endonuclease sites to obtain extraction probes; and (3) directly carrying out octadecylsilylating on the hydroxylated silicon dioxide buoyancy microsphere to obtain the collecting probe.
The invention is realized by the following technical scheme:
1) the DNA molecule containing the endonuclease site is formed by hybridization of DNA1 and DNA 2. The 5' end of the DNA1 is modified with carboxyl for covalent coupling with aminophenylboronic acid; the 3' end is modified with sulfydryl and is used for being covalently connected to a maleamide group on the buoyant microsphere.
2) The extraction probe takes hydroxylated buoyancy microspheres as a carrier, amino silanization is firstly carried out, then a maleamide group is covalently modified, and finally DNA molecules containing endonuclease sites are covalently assembled; the collection probes were obtained by direct octadecylsilylation of hydroxylated buoyant microspheres as shown in figure 1.
The working principle of the invention is as follows:
the working principle of the invention is shown in figure 2: the extraction probes were first incubated with the cells on a vertical rotator and centrifuged intermittently. After several cycles, the extraction probes were separated from the cells by buoyancy under centrifugation. The extraction probe is then incubated with an endonuclease to cleave the extracted sialic acid group-containing biomolecule, along with the bound nucleic acid fragments, into solution. After removal of the extraction probe by buoyancy, a collection probe was added to the purge solution. After incubating for a period of time on a vertical rotation instrument, separating and collecting probes through buoyancy; and adding the initiation DNA of the hybrid chain reaction and a pair of hairpin DNAs into the collected probe dispersion liquid to perform hybrid chain reaction to obtain a fluorescent signal. And (3) obtaining a standard curve by using a standard ganglioside solution, and quantitatively detecting the cell surface ganglioside.
Compared with the prior art, the invention has the following characteristics:
the size of the buoyancy microsphere used in the invention is close to that of cells, and the buoyancy microsphere has the characteristics of rapid buoyancy separation capability and easy modification. The prepared extraction probe can efficiently and quickly act and separate with cells, and realizes the non-destructive extraction of the cell surface ganglioside. The prepared collecting probe can specifically collect the released ganglioside through hydrophobic interaction, and further obtains a sensitive fluorescent signal by utilizing hybridization chain reaction, thereby realizing the quantitative detection of the cell surface ganglioside.
Compared with the existing ganglioside detection method, the method has the following advantages:
1. the buoyancy microsphere probe is simple and convenient in preparation method and has high specific extraction capacity and collection capacity. The extraction process does not require cell disruption and other pretreatment steps, and is advantageous over prior methods.
2. The DNA functional molecule can efficiently release the captured biomolecule containing sialic acid group under the action of endonuclease. The nucleic acid fragments bound to gangliosides can trigger hybridization chain reactions, resulting in signal amplification.
Description of the drawings
FIG. 1 is a schematic diagram of the structure and synthesis of two buoyancy microsphere probes
FIG. 2 is a schematic diagram of the detection of cell surface ganglioside by two buoyant microsphere probes
Fifth, detailed description of the invention
Example 1: combining with figure 1, synthesizing buoyancy microsphere probe capable of quantitatively screening cell surface ganglioside
Disperse in hybridization buffer (TE +100mM NaCl and 10mM MgCl)2pH 8.0) of 100. mu.L of DNA1 (10. mu.M) and 100. mu.L of DNA2 (10. mu.M) were incubated at 37 ℃ with mixingAnd (4) at night. The resulting hybridization product was centrifuged with a 10Kd ultrafiltration tube and dispersed in phosphate buffer (PBS, pH 7.4). Then, 20. mu.L of aminobenzeneboronic acid (APBA, 500. mu.M) and 20. mu.L of 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide (EDC, 500. mu.M) were added thereto, respectively, and stirred at room temperature overnight. The resulting functional DNA molecule (HS-DNA1/2-APBA) was centrifuged with a 10Kd ultrafiltration centrifuge tube and dispersed in TE buffer for further use.
Silica buoyant microspheres (about 2.5X 10)7One) was first stirred overnight with piranha (30% hydrogen peroxide: 98% sulfuric acid 1: 3) on a vertical rotary stirrer. The obtained hydroxylated buoyancy microspheres are washed and dried, and then stirred overnight with 1mL of 5% amino silanization reagent dissolved in methanol. The obtained amino silanized buoyant microspheres were washed twice with methanol and Dimethylformamide (DMF), dispersed into a DMF solution containing succinimide and maleimide di-modified polyethylene glycol (NHS-PEG-Mal, 100mM) and N, N-diisopropylethylamine (DIPEA, 150mM), stirred overnight at room temperature, and then washed twice with DMF and water. And finally, adding 100 mu L of 1 mu M HS-DNA1/2-APBA into the obtained buoyancy microsphere modified with maleimide groups, stirring overnight at room temperature, and washing twice with water to obtain the extraction probe.
Hydroxylated silica buoyant microspheres (about 1.5X 10)6One) was added to a methanol solution containing 5% octadecylsilane reagent, stirred overnight at room temperature, and washed twice with methanol and PBS to obtain a collection probe.
Example 2: with reference to FIG. 2, quantitative determination of gangliosides on cell surface was performed using a buoyant microsphere probe
MCF-7 cells (50. mu.L, 1.2X 10) were used as a basic model for MCF-7 breast cancer cell lines5mL-1) And extraction probe (50. mu.L, 9.6X 10)5mL-1) After mixing and shaking in PBS solution for 55 minutes, it was centrifuged at 1000rpm for 5 minutes. After 4 cycles, centrifugation was performed, and the floated extraction probe was taken out by buoyancy, washed twice with PBS, and added to 100. mu.L of an enzyme digestion buffer containing 2% Eco47 III. Stirring, incubating for 15 min, centrifuging, removing floating extraction probe by buoyancy, adding into the lower solution10 μ L of collection probe (9X 10)4mL-1) After incubation for two hours at room temperature with stirring, the cells were centrifuged and washed twice with PBS. The resulting collected ganglioside-collected collection probe was added to 100. mu.L of hybridization buffer containing hybridization chain reaction primer (1. mu.M), hybridization chain reaction hairpin H1 (10. mu.M) and H2 (10. mu.M), and mixed and incubated at 37 ℃ for 4 hours. The resulting collection probe was centrifuged, washed twice with TE, and fluorescence imaged to obtain a quantitative fluorescent signal.
Standard solutions of ganglioside GD1a at different concentrations (50. mu.L, 0.5, 1.0, 1.5, 2.0, 2.5nM) were mixed with extraction probes (50. mu.L, 9.6X 10, respectively)5mL-1) And (3) incubating in a PBS solution, performing enzyme digestion, collection and hybridization chain reaction by using the same method to obtain a standard curve, and combining a fluorescence signal of a cell experiment to obtain a quantitative detection result of the cell surface ganglioside.
Claims (3)
1. A buoyancy microsphere probe for quantitatively screening cell surface ganglioside is characterized by comprising an extraction probe and a collection probe; the extraction probe takes silicon dioxide buoyancy microspheres as a carrier and respectively loads functional DNA molecules with endonuclease Eco47III cutting sites and boric acid terminals; the functional DNA molecule is formed by hybridizing DNA1 and DNA2, the 3' end of the DNA1 is sulfydryl, and the DNA molecule is connected to the carbon dioxide buoyancy microsphere subjected to amino silanization through a succinimide and maleimide double-modified polyethylene glycol chain; the 5' end of the DNA1 is carboxyl, and is used for specifically identifying and extracting biomolecules containing sialic acid groups on the cell surface by covalently bonding aminophenylboronic acid molecules; the DNA2 is hybridized with the middle part of the DNA1 to form a cutting site of an endonuclease Eco47 III; the extraction probe can rapidly act on and separate from cells, so that the non-destructive extraction of the cell surface ganglioside is realized; the collecting probe is obtained by directly performing octadecyl silanization on the hydroxylated silicon dioxide buoyancy microsphere, the collecting probe performs specific collection on the released ganglioside through hydrophobic effect, and a fluorescence signal is further obtained by utilizing a hybrid chain reaction, so that quantitative detection of the cell surface ganglioside is realized.
2. The buoyant microsphere probe of claim 1, wherein the collected sialic acid group containing biomolecules on the surface of the extraction probe are cleaved with the endonuclease Eco47III and released into solution along with the bound nucleic acid fragments, and the ganglioside containing molecules in the release are collected by the collection probe.
3. The buoyant microsphere probe of claim 1, wherein the ganglioside-containing molecules collected on the surface of the collection probe can hybridize with the priming sequence via the nucleic acid fragments bound thereto, and initiate a hybridization chain reaction to obtain a fluorescent signal.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711272434.7A CN109870433B (en) | 2017-12-01 | 2017-12-01 | Buoyancy microsphere probe for quantitative screening of ganglioside and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711272434.7A CN109870433B (en) | 2017-12-01 | 2017-12-01 | Buoyancy microsphere probe for quantitative screening of ganglioside and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109870433A CN109870433A (en) | 2019-06-11 |
CN109870433B true CN109870433B (en) | 2021-06-15 |
Family
ID=66915233
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711272434.7A Active CN109870433B (en) | 2017-12-01 | 2017-12-01 | Buoyancy microsphere probe for quantitative screening of ganglioside and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109870433B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115960160A (en) * | 2021-10-12 | 2023-04-14 | 南京大学 | Live cell membrane integrin alpha v β 3 Method for in situ sugar chain extension of glycans |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004099407A1 (en) * | 2003-05-09 | 2004-11-18 | Chemical Biology Institute | Method of testing sensitivity to anticancer drug |
CN1553188A (en) * | 2003-06-06 | 2004-12-08 | 克 宋 | Microarray signal amplifying method |
CN1914335A (en) * | 2004-02-06 | 2007-02-14 | Isis药物公司 | Antisense oligonucleotide modulation of STAT3 expression |
EP2026067A1 (en) * | 2006-05-30 | 2009-02-18 | Japan Science and Technology Agency | Method for detection of disease having insulin-resistant condition |
WO2011126126A1 (en) * | 2010-04-06 | 2011-10-13 | 住友化学株式会社 | NON-HUMAN ANIMAL DEFICIENT IN Gm1 GENE PRODUCT AND METHOD OF UTILIZATION THEREOF |
CN103418295A (en) * | 2007-06-21 | 2013-12-04 | 简.探针公司 | Appratus and means for contents of mixing detection receptacle |
CN105378450A (en) * | 2013-02-18 | 2016-03-02 | 赛拉诺斯股份有限公司 | Systems and methods for multi-analysis |
CN206450638U (en) * | 2016-09-30 | 2017-08-29 | 珠海赛隆药业股份有限公司 | The GM1 detection chromatographic column of high-purity |
-
2017
- 2017-12-01 CN CN201711272434.7A patent/CN109870433B/en active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004099407A1 (en) * | 2003-05-09 | 2004-11-18 | Chemical Biology Institute | Method of testing sensitivity to anticancer drug |
CN1553188A (en) * | 2003-06-06 | 2004-12-08 | 克 宋 | Microarray signal amplifying method |
CN1914335A (en) * | 2004-02-06 | 2007-02-14 | Isis药物公司 | Antisense oligonucleotide modulation of STAT3 expression |
EP2026067A1 (en) * | 2006-05-30 | 2009-02-18 | Japan Science and Technology Agency | Method for detection of disease having insulin-resistant condition |
CN103418295A (en) * | 2007-06-21 | 2013-12-04 | 简.探针公司 | Appratus and means for contents of mixing detection receptacle |
WO2011126126A1 (en) * | 2010-04-06 | 2011-10-13 | 住友化学株式会社 | NON-HUMAN ANIMAL DEFICIENT IN Gm1 GENE PRODUCT AND METHOD OF UTILIZATION THEREOF |
CN105378450A (en) * | 2013-02-18 | 2016-03-02 | 赛拉诺斯股份有限公司 | Systems and methods for multi-analysis |
CN206450638U (en) * | 2016-09-30 | 2017-08-29 | 珠海赛隆药业股份有限公司 | The GM1 detection chromatographic column of high-purity |
Also Published As
Publication number | Publication date |
---|---|
CN109870433A (en) | 2019-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wan et al. | Rapid magnetic isolation of extracellular vesicles via lipid-based nanoprobes | |
Kang et al. | High-purity capture and release of circulating exosomes using an exosome-specific dual-patterned immunofiltration (ExoDIF) device | |
Mohammadi et al. | Emerging technologies and commercial products in exosome-based cancer diagnosis and prognosis | |
US20130123121A1 (en) | Methods and/or Use of Oligonucleotide-Bead Conjugates for Assays and Detections | |
US20130344508A1 (en) | Methods and/or Use of Oligonucleotide Conjugates for Suppressing Background Due to Cross-Hybridization | |
JPWO2015045666A1 (en) | Fluid device, exosome analysis method, biomolecule analysis method, and biomolecule detection method | |
WO2018090651A1 (en) | Method for pretreating protein in ex vivo body fluid | |
US20180105778A1 (en) | Multi-stage purification method and apparatus of extracellular vesicles using aqueous solution two-phase system | |
CN102658098A (en) | Boron affine functionalization material, preparation and application with adjacent hydroxyl methyl benzene boric acid serving as functional monomer | |
US20190276820A1 (en) | Single extracellular vesicle multiplexed protein and rna analysis | |
CN109870433B (en) | Buoyancy microsphere probe for quantitative screening of ganglioside and preparation method thereof | |
EP1373573A4 (en) | Conjugate probes and optical detection of analytes | |
Miranda-Castro et al. | The translational potential of electrochemical DNA-based liquid biopsy | |
CN111073846A (en) | Method for separating extracellular vesicles from tissue specific sources and kit thereof | |
Pallares-Rusiñol et al. | Advances in exosome analysis | |
CN109553797A (en) | A kind of preparation and its Application in Sensing of functionalization three-dimensional graphene composite material | |
KR20200054268A (en) | Detection of recombinase polymerase amplification using a double-hapten probe | |
JP2023100770A (en) | Manufacturing device and manufacturing method for exosome liquid biopsy sample | |
US20210379591A1 (en) | Fragmentation of target molecules for sequencing | |
Chen et al. | Quantitative Screening of Cell‐Surface Gangliosides by Nondestructive Extraction and Hydrophobic Collection | |
CN101470111B (en) | Preparation and use of novel nano-Au composite substrate NCS | |
CN107976548A (en) | Detection fibrin ferment kit based on tetra- serobilas of micro-fluidic chip and G--ferroheme DNA enzymatic and its preparation method and application | |
US8975017B2 (en) | Process for concentrating nucleic acid molecules | |
CN104177451A (en) | Non-natural difunctional saccharides, and preparing methods and applications thereof | |
CA3177368A1 (en) | Devices and methods for sequencing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |